Kaldyum

Potassium Chloride, the active ingredient in Kaldyum, is an electrolyte supplement presented as an oral formulation for oral use. It helps restore normal serum potassium levels in patients with hypokalemia and other potassium deficiencies.

GNH USA supplies Kaldyum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaldyum is an oral electrolyte supplement used to correct low potassium states and support normal cardiac and muscular function.

- Hypokalemia: restores serum potassium to normal ranges in patients with documented low potassium levels. - Potassium deficiency: provides supplemental potassium to prevent or treat deficiency due to inadequate intake. - Diuretic‑induced potassium loss: helps maintain potassium balance in patients receiving potassium‑depleting diuretics.

Kaldyum may cause a range of adverse reactions, most of which are related to the potassium load and gastrointestinal irritation.

Common Side Effects: - Nausea: mild to moderate feeling of stomach upset. - Vomiting: occasional expulsion of stomach contents. - Abdominal discomfort: cramping or pain in the stomach area. - Diarrhea: loose stools occurring after ingestion. - Metallic taste: transient sensation of metal in the mouth.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium that can affect heart rhythm. - Cardiac arrhythmias: irregular heartbeats potentially leading to serious complications. - Severe gastrointestinal ulceration: rare but serious irritation of the stomach lining. - Anaphylactic reaction: extremely rare allergic response requiring immediate medical attention.

Before using Kaldyum, consider the following safety measures.

- Renal impairment: assess kidney function, as reduced excretion can increase hyperkalemia risk. - Cardiac disease: monitor ECG in patients with known heart conditions. - Concomitant potassium‑sparing drugs: avoid additive potassium load. - Gastrointestinal disorders: use cautiously in patients with ulcer disease or severe gastritis. - Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Kaldyum can interact with several medicines that affect potassium balance or cardiac conduction.

Major Interactions (Avoid): - ACE inhibitors (e.g., enalapril): may cause additive hyperkalemia. - Angiotensin II receptor blockers (e.g., losartan): increase potassium levels. - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia. - NSAIDs (e.g., ibuprofen): can impair renal potassium excretion. - Digoxin: elevated potassium may alter digoxin toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers (e.g., metoprolol): may mask symptoms of hyperkalemia. - Corticosteroids (e.g., prednisone): can affect potassium balance. - Laxatives (e.g., senna): may increase gastrointestinal loss of potassium. - Antacids containing aluminum or magnesium: may affect absorption. - Certain antibiotics (e.g., trimethoprim‑sulfamethoxazole): can raise potassium levels.